Manganism (Manganese Toxicity): Symptoms, Causes, and Risks

Manganese is an essential mineral — your body genuinely needs a small amount of it — but too much of it, absorbed over time, can be a potent neurotoxin. The classic illness it causes is called manganism: a movement and mood disorder that looks a lot like Parkinson's disease, with slowness, stiffness, tremor, clumsiness, irritability, and trouble thinking clearly. Here is the most important thing to understand at the outset: manganism almost never comes from food. A normal diet, even one rich in manganese, does not cause it, because the gut and liver tightly limit how much dietary manganese the body keeps. Real manganese toxicity comes from a different route entirely — breathing in manganese-laden fumes or dust (most famously in welders and miners), drinking water with unusually high manganese, receiving manganese intravenously (as in long-term IV nutrition that bypasses the gut's safeguards), or, rarely, an inherited disorder that lets the metal build up. This hub explains what manganism is, why excess manganese is dangerous, why early cases are often missed, what actually causes it, how it is diagnosed, and how it is managed — with deep-dive pages on its movement symptoms, its mood and thinking effects, and the occupational and water exposures behind it. If you suspect a manganese exposure, this is medical territory; talk to a clinician rather than self-treating.

Symptom Deep-Dive Pages

Table of Contents

1. Symptom Deep-Dive Pages
2. What Is Manganism (Manganese Toxicity)?
3. Why Excess Manganese Is Dangerous
4. Why Early Manganism Is Often Missed
5. What Actually Causes Manganese Toxicity
6. How Manganese Toxicity Is Diagnosed
7. How Manganese Toxicity Is Managed
8. When to Seek Care / Red Flags
9. Key Research Papers
10. Connections
11. Featured Videos

What Is Manganism (Manganese Toxicity)?

Manganese is a trace mineral that every cell needs in small amounts — it is built into enzymes that defend the body against oxidative damage, help bones form, and process sugars and proteins. (For the helpful side of manganese, see the Manganese overview and the Manganese Benefits hub.) But like several other essential metals, manganese has a narrow safe range. Below it, you can develop a deficiency; well above it, the same mineral becomes toxic. Manganese toxicity is the condition that develops when too much manganese accumulates in the body — especially in the brain — over weeks to years. The neurological illness it produces is called manganism.

Manganism was first recognized almost two centuries ago in workers who ground and milled manganese ore, and the picture has been confirmed many times since in miners, smelter and battery workers, and welders. The hallmark is a movement disorder that closely resembles Parkinson's disease: people become slow and stiff, develop a stooped posture and a peculiar high-stepping or "cock-walk" gait, and may have a tremor, a blank facial expression, and soft, monotonous speech. Alongside — and often before — the movement problems, many develop psychological changes: irritability, mood swings, anxiety, emotional outbursts, and difficulty with concentration and memory. The two deep-dive pages on Tremor & Parkinsonism and Mood & Cognitive Changes cover each cluster in detail.

Unlike potassium or calcium, manganese does not have a single, universally agreed blood number that defines "toxic." A blood manganese level above roughly 15–20 micrograms per liter is often considered elevated, but here is a crucial caveat that runs through this whole topic: blood manganese is an unreliable yardstick. Manganese spends most of its time inside cells and in the brain, not floating in the bloodstream, and the blood level can be near-normal in someone whose brain has accumulated a damaging amount — or transiently high in someone with no symptoms at all. Diagnosis therefore leans heavily on the exposure history, the clinical picture, and a brain MRI, as the diagnosis section explains.

The single most reassuring fact about manganese toxicity is also the most important: it essentially never comes from eating ordinary food. Whole grains, nuts, leafy greens, and tea are naturally rich in manganese, yet they do not cause manganism, because the digestive tract absorbs only a small fraction of dietary manganese and the liver promptly clears the excess into bile. Real toxicity comes from routes that overwhelm or bypass these defenses — chiefly inhaled fumes and dust, contaminated water, and intravenous delivery — which the causes section covers in full.

Back to Table of Contents

Why Excess Manganese Is Dangerous

If manganese is essential, why is too much of it so harmful? The answer lies in where excess manganese goes and what it does once it gets there. When the body's normal limits are overwhelmed — by inhalation, contaminated water, or IV delivery — manganese crosses into the brain and preferentially accumulates in a cluster of deep structures called the basal ganglia, especially a region known as the globus pallidus. These structures are the brain's movement-control hub, which is exactly why the resulting illness looks like a Parkinson-type disorder.

Inside those brain cells, surplus manganese is thought to cause harm through several overlapping mechanisms that researchers have pieced together over decades:

• Oxidative stress. Manganese is a metal that can cycle between chemical states and promote the formation of reactive, tissue-damaging molecules (free radicals). In excess it tips the balance toward oxidative damage, injuring the very neurons it accumulates in. There is an irony here: at normal levels manganese is part of the body's antioxidant defense (it sits at the core of an enzyme called manganese superoxide dismutase), but in excess it becomes a pro-oxidant.
• Mitochondrial trouble. Manganese concentrates inside mitochondria, the cell's power plants, where it can impair energy production and further fuel free-radical formation — a one-two punch that neurons, with their huge energy demands, tolerate poorly.
• Disrupted neurotransmitters. Manganese interferes with the brain's chemical messengers in the basal ganglia, including dopamine signaling. This overlaps with — but is not identical to — the dopamine loss of Parkinson's disease, which is part of why the two conditions resemble each other yet respond differently to treatment.
• Inflammation. Excess manganese activates the brain's resident immune cells (microglia and astrocytes), and the resulting low-grade inflammation contributes to the ongoing neuronal injury.

A defining and sobering feature of manganism is that the damage tends to be cumulative and often only partly reversible. Catching exposure early and stopping it can halt progression and allow some recovery, but in advanced cases the movement disorder can persist, or even continue to worsen for a time, after the exposure has ended — because the structural injury to the basal ganglia has already been done. This is unlike a passing electrolyte disturbance that corrects when the number normalizes; manganism is closer to a slow poisoning of a specific brain region. That is why prevention and early detection matter so much more than treatment after the fact. The detailed neurological consequences are explored on the Tremor & Parkinsonism page.

Back to Table of Contents

Why Early Manganism Is Often Missed

Manganese toxicity is rarely dramatic at the start. It does not announce itself the way a poisoning or an acute illness might. Instead it tends to creep in slowly and disguise itself as something ordinary, which is precisely why early cases are so often overlooked — by the affected person, their family, and sometimes their doctors too.

Several things conspire to keep early manganism hidden:

• The first symptoms are vague and "psychological." The earliest changes are frequently irritability, moodiness, anxiety, restlessness, trouble sleeping, and slips in concentration or memory. These are easy to attribute to stress, a hard job, depression, or just getting older. A welder who has become short-tempered and forgetful is far more likely to be told to take a break than to be tested for a metal. The Mood & Cognitive Changes page covers this early phase in depth.
• It develops gradually. Because manganese accumulates over months to years, there is no single moment of onset to point to. The slide is slow enough that people adapt to it and may not notice how much has changed.
• The blood test can look normal. As noted above, blood manganese is a poor reflection of how much has built up in the brain. A reassuring-looking blood level can give false comfort, and a clinician not already thinking about manganese may be steered away from the diagnosis.
• It mimics common conditions. Once movement symptoms appear, the natural assumption — especially in an older person — is Parkinson's disease. Without the exposure history in mind, manganism can be misdiagnosed as ordinary parkinsonism, and the chance to remove the exposure is lost.

The practical upshot is that the exposure history is often the key that unlocks the diagnosis. Manganism should be considered in anyone with unexplained parkinsonian or neuropsychiatric symptoms who has a relevant exposure — years of welding, mining, smelting, or battery work; long-term intravenous nutrition; or a high-manganese water supply. This is also why surveillance matters for at-risk workers: like other slow occupational hazards, manganese is better caught by deliberately looking for it than by waiting for someone to complain. The Occupational & Water Exposure page describes who is at risk and how exposure is monitored.

Back to Table of Contents

What Actually Causes Manganese Toxicity

Understanding the real causes of manganism means understanding how the body normally protects itself — and how each cause defeats those protections. In a healthy person eating a normal diet, two safeguards keep manganese in check: the intestine absorbs only a small percentage of the manganese in food, and the liver rapidly removes any excess by excreting it into bile (which leaves the body in stool). Toxicity happens when these defenses are bypassed (manganese enters by a route the gut and liver don't guard), overwhelmed (the dose is enormous), or broken (the liver or the genes that clear manganese aren't working). Here are the routes that matter.

• Inhalation — the classic and most important cause. Breathing in manganese-containing fumes or fine dust is the leading route to manganism, and it is dangerous for a specific reason: inhaled manganese bypasses the gut and the liver almost entirely. Tiny particles can travel from the lungs — and even along the nerves of the nose — more or less directly toward the brain, sidestepping the digestive safeguards that make dietary manganese harmless. The highest-risk jobs are welding (manganese is a key ingredient in steel and welding consumables), manganese mining and ore processing, smelting and ferroalloy production, steel manufacturing, and dry-cell battery production. Communities living near ferroalloy plants and smelters can also be exposed through airborne emissions. This is the focus of the Occupational & Water Exposure page.
• Intravenous nutrition (TPN). People who cannot eat and are fed entirely through a vein — called total parenteral nutrition, or TPN — receive manganese directly into the bloodstream, completely bypassing the intestine's gatekeeping. If the manganese content is too high or given for too long, levels can build up and cause brain accumulation, which is why manganese in long-term IV nutrition is now carefully limited and monitored. Infants and people with liver disease on TPN are especially vulnerable.
• Liver disease. Because the liver is the body's main exit route for manganese (via bile), serious liver disease — especially advanced cirrhosis — can let manganese accumulate even without extra intake. This is one reason some people with chronic liver failure develop a parkinsonian movement disorder and the characteristic brain-MRI changes of manganese deposition. See Liver Disease.
• High-manganese drinking water. Manganese occurs naturally in soil and rock and can dissolve into groundwater, so some private wells contain high levels. The U.S. EPA's health-based guidance for manganese in drinking water is 0.3 mg/L (300 micrograms per liter), with an older aesthetic guideline of 0.05 mg/L set mainly to avoid staining and off-taste. Several studies — discussed in the research section — have linked high-manganese water to lower cognitive scores and behavioral changes in children, who appear to be more vulnerable than adults. People on well water in manganese-rich areas, especially households with young children, are the group to think about here.
• Inherited manganese-transport disorders — rare. A small number of people are born with mutations in genes (such as SLC30A10 and SLC39A14) that normally help shuttle manganese out of the body. Without working transporters, manganese accumulates from infancy or childhood even on a normal diet, causing a hereditary form of manganism with dystonia, liver disease, and distinctive blood findings. These conditions are uncommon, but they vividly demonstrate that manganism is fundamentally a problem of clearance, not just intake.
• What does not cause it: ordinary food and typical supplements. It bears repeating, because it is the question most people actually have. A manganese-rich diet does not cause manganism in people with healthy guts and livers. Standard multivitamins, which contain modest amounts of manganese, are likewise not a recognized cause of toxicity in healthy adults. The risk from oral intake rises only in specific situations — very high-dose isolated supplements taken long term, or any intake combined with liver disease or an inherited transport defect.

A practical theme ties these together: manganese toxicity is overwhelmingly a disease of route and clearance, not of healthy eating. The dangerous routes are the ones that skip the gut and liver (inhalation, IV) or that arise when clearance fails (liver disease, genetic defects) or when the dose in water is high and chronic.

Back to Table of Contents

How Manganese Toxicity Is Diagnosed

There is no single test that confirms manganism by itself. Instead, the diagnosis is assembled from three things that have to be read together: the exposure history, the clinical picture, and brain imaging, with laboratory tests playing a supporting — and notably limited — role.

• The exposure history — the most important step. Because the symptoms overlap so heavily with Parkinson's disease and with everyday stress, the diagnosis usually begins with a clinician asking the right questions: What is (or was) your work? Years of welding, mining, smelting, steel or battery work? Are you fed intravenously? Do you have liver disease? What is your water source? A relevant exposure transforms vague symptoms into a specific suspicion.
• The clinical examination. A neurologist looks for the combination that points toward manganism rather than typical Parkinson's: prominent gait and balance problems early on (including the distinctive "cock-walk"), a tremor that is often more postural than the classic resting tremor of Parkinson's, relatively symmetric findings, and accompanying neuropsychiatric changes. Importantly, manganism characteristically responds poorly to levodopa (L-DOPA), the mainstay drug for Parkinson's — a poor response is itself a diagnostic clue. The detailed comparison is on the Tremor & Parkinsonism page.
• Brain MRI — the most useful test. Manganese is paramagnetic, which means deposits show up as a characteristic bright (high) signal on T1-weighted MRI in the basal ganglia, especially the globus pallidus. This pattern, in the right context, is strong supporting evidence of manganese accumulation. (It is the same imaging signature seen in some people with advanced liver disease, reflecting the shared mechanism of manganese buildup.) The bright signal tends to fade over months once exposure stops, so MRI can also help track whether accumulation is ongoing.
• Blood and urine manganese — supportive but unreliable. A blood (whole-blood) manganese level can document a recent or ongoing exposure and is often part of the workup, but as stressed throughout this page, a normal blood level does not rule out toxicity, and levels fall relatively quickly once exposure ends. Urine and hair manganese are sometimes measured, particularly in research and in environmental investigations, but they too are imperfect markers. The lesson is that no single number should be trusted over the whole clinical picture.
• Tests to exclude other causes. Because manganism is partly a diagnosis of pattern-recognition, doctors also look for and rule out other explanations for a parkinsonian or neuropsychiatric syndrome — including idiopathic Parkinson's disease (see Parkinson's Disease), other metal exposures, and liver disease. Liver function and related testing may be done given the liver's central role in manganese clearance.

For the routine blood panels that include liver and metabolic markers often checked along the way, see the Comprehensive Metabolic Panel page.

Back to Table of Contents

How Manganese Toxicity Is Managed

The honest headline on treatment is that there is no reliable cure for established manganism, and the available therapies are only partly effective. This is exactly why the emphasis falls so heavily on removing the exposure and on prevention. Management has three broad strands.

• Stop the exposure — the single most important step. Above all else, the source of excess manganese must be removed. For a worker, that means leaving the dusty or fume-filled environment, or fixing it with proper ventilation, respiratory protection, and engineering controls. For someone on IV nutrition, it means adjusting or reducing the manganese in the formula. For a household, it means treating or replacing high-manganese water. Stopping exposure can halt progression and allow partial recovery, and it is the intervention with the clearest benefit. (Practical prevention is detailed on the Occupational & Water Exposure page.)
• Chelation — of limited and uncertain benefit. Chelating agents are drugs that bind metals so they can be excreted; one called EDTA (specifically CaNa₂EDTA) can increase manganese excretion in the urine. In practice, however, chelation for manganism has shown inconsistent results — it can lower measured manganese and sometimes improve symptoms modestly, but it does not reliably reverse the neurological injury, especially once it is established. It is not a guaranteed fix, and it carries its own risks, so it is used selectively and under specialist care. Researchers have also studied other agents (such as the iron-related drug PAS, para-aminosalicylic acid) with some promising but not definitive results.
• Treating the symptoms. Because the underlying brain injury is hard to reverse, much of care is supportive — aimed at helping people function and feel better:
  • Levodopa (L-DOPA) is often tried because the picture resembles Parkinson's, but, as noted, manganism typically responds poorly or not at all — another way the two conditions are distinguished. Some patients get limited benefit.
  • Physical, occupational, and speech therapy help maintain mobility, balance, daily function, and communication.
  • Treatment of mood and cognitive symptoms — addressing depression, anxiety, irritability, and sleep — can meaningfully improve quality of life even when the movement disorder is fixed. See Mood & Cognitive Changes.

The realistic outlook is mixed and depends heavily on timing. Caught early, with exposure stopped, some people stabilize and partially recover. Caught late, the movement disorder can persist or progress despite every intervention. That gap between "early and reversible" and "late and permanent" is the strongest argument for taking exposure seriously and acting before symptoms become entrenched — treatment after the fact simply cannot do what prevention can.

Back to Table of Contents

When to Seek Care / Red Flags

Because manganese toxicity builds slowly and can become irreversible, the most valuable "red flag" is a relevant exposure combined with new neurological or mood symptoms — that combination warrants medical attention even if any single symptom seems minor. See a doctor (and mention the exposure explicitly) if you have a history of welding, mining, smelting, steel or battery work, long-term IV nutrition, liver disease, or high-manganese well water, and you develop any of the following:

• New tremor, stiffness, slowness, or clumsiness — trouble with fine movements, a shuffling or unusual gait, frequent stumbling, or a feeling that your body has become slow and rigid.
• Balance problems or falls — new unsteadiness, especially with the distinctive high-stepping walk described above.
• Persistent changes in mood or personality — new or worsening irritability, anxiety, emotional outbursts, low mood, or behaving unlike yourself, particularly if coworkers or family have noticed it too.
• New trouble with memory, concentration, or thinking speed — especially when it is progressing rather than stable.
• Parkinson-like symptoms that do not respond to levodopa — if you have been diagnosed with Parkinson's disease but the standard medication isn't helping and you have a manganese exposure history, it is worth revisiting the diagnosis.

Two situations deserve special urgency. First, anyone on long-term intravenous nutrition who develops movement or behavioral changes should be evaluated promptly, since the IV route can drive levels up quickly. Second, in a household using untreated well water in a manganese-rich area, children showing learning, attention, or behavioral difficulties are a reason to have the water tested. For the broader movement-disorder context, see Parkinson's Disease and Essential Tremor. As with any potential poisoning or toxic exposure, do not try to self-treat with supplements or chelating products bought online — manganism is genuine medical territory and benefits from specialist assessment.

Back to Table of Contents

Key Research Papers

1. O'Neal SL, Zheng W (2015). Manganese Toxicity Upon Overexposure: a Decade in Review. Current Environmental Health Reports;2(3):315-328. — DOI: 10.1007/s40572-015-0056-x
2. Guilarte TR (2010). Manganese and Parkinson's Disease: A Critical Review and New Findings. Environmental Health Perspectives;118(8):1071-1080. — DOI: 10.1289/ehp.0901748
3. Aschner M, Guilarte TR, Schneider JS, Zheng W (2007). Manganese: Recent advances in understanding its transport and neurotoxicity. Toxicology and Applied Pharmacology;221(2):131-147. — DOI: 10.1016/j.taap.2007.03.001
4. Racette BA, McGee-Minnich L, Moerlein SM, et al. (2001). Welding-related parkinsonism: Clinical features, treatment, and pathophysiology. Neurology;56(1):8-13. — DOI: 10.1212/wnl.56.1.8
5. Bowler RM, Koller W, Schulz PE (2006). Manganese exposure: Neuropsychological and neurological symptoms and effects in welders. NeuroToxicology;27(3):327-332. — DOI: 10.1016/j.neuro.2005.10.007
6. Lucchini RG, Guazzetti S, Zoni S, et al. (2012). Tremor, olfactory and motor changes in Italian adolescents exposed to historical ferro-manganese emission. NeuroToxicology;33(4):687-696. — DOI: 10.1016/j.neuro.2012.01.005
7. Bouchard MF, Sauvé S, Barbeau B, et al. (2011). Intellectual Impairment in School-Age Children Exposed to Manganese from Drinking Water. Environmental Health Perspectives;119(1):138-143. — DOI: 10.1289/ehp.1002321
8. Wasserman GA, Liu X, Parvez F, et al. (2011). Arsenic and Manganese Exposure and Children's Intellectual Function in Bangladesh. Epidemiology;22(1):117-118. — DOI: 10.1097/01.ede.0000391812.53279.3c
9. Bouchard M, Laforest F, Vandelac L, et al. (2007). Hair Manganese and Hyperactive Behaviors: Pilot Study of School-Age Children Exposed Through Tap Water. Environmental Health Perspectives / Epidemiology. — PubMed
10. Tuschl K, Mills PB, Clayton PT, et al. (2016). Hypermanganesemia with Dystonia, Polycythemia and Cirrhosis (HMDPC) due to mutation in the SLC30A10 gene. Brain and Development;38(9):862-865. — DOI: 10.1016/j.braindev.2016.04.005

PubMed Topic Searches

• PubMed — Manganism, manganese neurotoxicity, and parkinsonism
• PubMed — Welding fumes, manganese exposure, and neurological effects
• PubMed — Manganese in drinking water and children's cognition
• PubMed — Manganese, parenteral nutrition, and basal-ganglia MRI changes
• PubMed — SLC30A10 / SLC39A14 inherited manganese-transport disorders

Back to Table of Contents

Connections

• Manganism: Tremor & Parkinsonism
• Manganism: Mood & Cognitive Changes
• Manganism: Occupational & Water Exposure
• Manganese Overview
• Manganese Deficiency Hub
• Manganese Benefits Hub
• Parkinson's Disease
• Essential Tremor
• Liver Disease
• Comprehensive Metabolic Panel
• Iron
• Toxic Minerals

Back to Table of Contents

Featured Videos

×